EX-99.1 3 ex_730291.htm EXHIBIT 99.1 ex_730291.htm

Exhibit 99.1

 

logo.jpg
FOR IMMEDIATE RELEASE
A NASDAQ Listed Company: SGC  

 

 

SUPERIOR GROUP OF COMPANIES REPORTS FOURTH QUARTER 2024 RESULTS

 

– Total net sales of $145.4 million versus $147.2 million in prior year fourth quarter 
– Net income of $2.1 million versus $3.6 million in prior year fourth quarter 
– EBITDA of $7.3 million versus $9.9 million in prior year fourth quarter –
– Board of Directors approves additional stock repurchase plan
– Provides full-year outlook –

 

ST. PETERSBURG, Fla. – March 11, 2025 – Superior Group of Companies, Inc. (NASDAQ: SGC) (the “Company”), today announced its fourth quarter 2024 results.

 

“For 2024, we grew sales and diluted EPS 4% and 35%, respectively, while strengthening our balance sheet and making strategic investments in our people, services, products and technology.  Capping the year, our fourth quarter results came in as expected, placing us within our full-year outlook ranges which were raised in May of last year, and again reflecting back-end weighted results as anticipated,” said Michael Benstock, Chief Executive Officer. “While market conditions continue to reflect customer uncertainty, our team is demonstrating resilience and adaptability, and we are committed to tackling what we can control. Specifically, we are focused on cost management, operational efficiencies, customer experience and driving innovation, and when conditions turn we see tremendous opportunities for growth and market share opportunities across our three attractive end markets. Our outlook for 2025 reflects continued growth and margin expansion, and today our Board has approved a significant expansion of our share repurchase authorization.”

 

Fourth Quarter Results

 

For the fourth quarter ended December 31, 2024, net sales declined to $145.4 million compared to fourth quarter 2023 net sales of $147.2 million. Pretax income declined to $2.5 million compared to $4.2 million in the fourth quarter of 2023. Net income declined to $2.1 million or $0.13 per diluted share compared to $3.6 million or $0.22 per diluted share for the fourth quarter of 2023.

 

2025 Full-Year Outlook

 

The Company forecasts full-year 2025 net sales in the range of $585 million to $595 million, versus 2024 net sales of $565.7 million, and forecasts full-year earnings per diluted share in the range of $0.75 to $0.82, versus $0.73 in 2024

 
1

 

Stock Repurchase Plan

 

The Board of Directors approved a new stock repurchase plan which authorizes the Company to repurchase up to an additional $17.5 million worth of its common stock. This plan will be in effect upon completion or expiration of the previous plan approved by the Board of Directors on August 12, 2024, which had authorized the repurchase of up to $10 million and through which the Company had purchased 523,472 shares for $7.4 million through year-end 2024.

 

The new stock repurchase plan, which has no expiration date, allows the Company to purchase common stock from time to time through, among other ways, open market purchases, privately negotiated transactions, block purchases, and/or pursuant to Rule 10b5-1 trading plans, subject to certain requirements and factors. The number of shares purchased and the timing of any purchases will depend upon a number of factors, including the price and availability of the Company’s stock and general market conditions. Shares repurchased may be reissued later in connection with employee benefit plans and other general corporate purposes.

 

Second Amendment to Credit Agreement

 

On March 7, 2025, the Company, entered into a Second Amendment to the Credit Agreement among the Company, the domestic subsidiaries of the Company, as guarantors, the lenders party thereto (the “Lenders”), and PNC Bank, National Association, as administrative agent for the Lenders, pursuant to which the Company is now allowed to make restricted payments in an amount not to exceed $30 million in any fiscal year, up from $20 million previously, which increase will allow the Company greater flexibility in paying dividends and funding share repurchases. 

 

2

 

Webcast and Conference Call

 

The Company will host a webcast and conference call at 5:00 pm Eastern Time today. The live webcast and archived replay can be accessed in the investor relations section of the Company's website at https://ir.superiorgroupofcompanies.com/Presentations. Interested individuals may also join the teleconference by dialing 1-844-861-5505 for U.S. dialers and 1-412-317-6586 for International dialers. The Canadian Toll-Free number is 1-866-605-3852. Please ask to be joined to the Superior Group of Companies call. A telephone replay of the teleconference will be available through March 18, 2025. To access the replay, dial 1-877-344-7529 in the United States or 1-412-317-0088 from international locations. Canadian dialers can access the replay at 855-669-9658. Please reference conference number 8841600 for replay access.

 

Disclosure Regarding Forward Looking Statements

 

Certain matters discussed in this press release are “forward-looking statements” intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements can generally be identified by use of the words “may,” “will,” “should,” “could,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” “project,” “potential,” or “plan” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements in this press release may include, without limitation: (1) projections of revenue, income, and other items relating to our financial position and results of operations, including short-term and long-term plans for cash (2) statements of our plans, objectives, strategies, goals and intentions, (3) statements regarding the capabilities, capacities, market position and expected development of our business operations and (4) statements of expected industry and general economic trends.

 

Such forward-looking statements are subject to certain risks and uncertainties that may materially adversely affect the anticipated results. Such risks and uncertainties include, but are not limited to, the following: the impact of competition; uncertainties related to a potential trade war, supply disruptions, inflationary environments (including with respect to shipping costs and the cost of finished goods and raw materials and shipping costs), employment levels (including labor shortages), and general economic and political conditions in the areas of the world in which the Company operates or from which it sources its supplies or the areas of the United States of America (“U.S.” or “United States”) in which the Company’s customers are located; changes in the healthcare, retail chain, food service, transportation and other industries where uniforms and service apparel are worn; our ability to identify suitable acquisition targets, discover liabilities associated with such businesses during the diligence process, successfully integrate any acquired businesses, or successfully manage our expanding operations; the price and availability of raw materials; attracting and retaining senior management and key personnel; the effect of the Company’s previously disclosed material weakness in internal control over financial reporting; the Company’s ability to successfully remediate its material weakness in internal control over financial reporting and to maintain effective internal control over financial reporting; and other factors described in the Company’s filings with the Securities and Exchange Commission, including those described in the “Risk Factors” section of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements made herein and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are only made as of the date of this press release and we disclaim any obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances, except as may be required by law.

 

About Superior Group of Companies, Inc. (SGC):

 

Established in 1920, Superior Group of Companies is comprised of three attractive business segments each serving large, fragmented and growing addressable markets. Across Healthcare Apparel, Branded Products and Contact Centers, each segment enables businesses to create extraordinary brand engagement experiences for their customers and employees. SGC’s commitment to service, quality, advanced technology, and omnichannel commerce provides unparalleled competitive advantages. We are committed to enhancing shareholder value by continuing to pursue a combination of organic growth and strategic acquisitions. For more information, visit www.superiorgroupofcompanies.com.

 

Investor Relations Contact:

 

[email protected]

 

3

 

Comparative figures are as follows:

 

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except shares and per share data)

 

   

Three Months Ended December 31,

   

Years Ended December 31,

 
   

2024

   

2023

   

2024

   

2023

 

Net sales

  $ 145,408     $ 147,241     $ 565,676     $ 543,302  
                                 

Costs and expenses:

                               

Cost of goods sold

    91,448       91,809       345,098       339,755  

Selling and administrative expenses

    50,020       49,198       199,926       184,060  

Interest expense

    1,461       2,060       6,358       9,718  
      142,929       143,067       551,382       533,533  

Income before income tax expense

    2,479       4,174       14,294       9,769  

Income tax expense

    390       617       2,290       997  

Net income

  $ 2,089     $ 3,557     $ 12,004     $ 8,772  
                                 

Net income per share:

                               

Basic

  $ 0.13     $ 0.22     $ 0.75     $ 0.55  

Diluted

  $ 0.13     $ 0.22     $ 0.73     $ 0.54  
                                 

Weighted average shares outstanding during the period:

                               

Basic

    15,675,402       16,010,006       16,008,015       15,968,199  

Diluted

    16,250,792       16,238,736       16,504,384       16,159,308  
                                 

Cash dividends per common share

  $ 0.14     $ 0.14     $ 0.56     $ 0.56  

 

4

 

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except share and par value data)

 

   

December 31,

 
   

2024

   

2023

 

ASSETS

               

Current assets:

               

Cash and cash equivalents

  $ 18,766     $ 19,896  

Accounts receivable

    95,092       103,494  

Inventories

    96,675       98,067  

Contract assets

    51,688       48,715  

Prepaid expenses and other current assets

    10,831       9,188  

Total current assets

    273,052       279,360  

Property, plant and equipment, net

    41,879       46,890  

Operating lease right-of-use assets

    15,567       17,909  

Deferred tax asset

    13,835       12,356  

Intangible assets, net

    51,137       51,160  

Goodwill

    2,304       -  

Other assets

    17,360       14,775  

Total assets

  $ 415,134     $ 422,450  
                 

LIABILITIES AND SHAREHOLDERS’ EQUITY

               

Current liabilities:

               

Accounts payable

  $ 50,942     $ 50,520  

Other current liabilities

    44,367       43,978  

Current portion of long-term debt

    5,625       4,688  

Current portion of acquisition-related contingent liabilities

    814       1,403  

Total current liabilities

    101,748       100,589  

Long-term debt

    80,410       88,789  

Long-term pension liability

    13,315       13,284  

Long-term acquisition-related contingent liabilities

    935       557  

Long-term operating lease liabilities

    10,486       12,809  

Other long-term liabilities

    9,384       8,784  

Total liabilities

    216,278       224,812  

Commitments and contingencies

               

Shareholders’ equity:

               

Preferred stock, $.001 par value - authorized 300,000 shares (none issued)

    -       -  

Common stock, $.001 par value - authorized 50,000,000 shares, issued and outstanding - 16,484,921 and 16,564,712 shares, respectively

    16       16  

Additional paid-in capital

    84,060       77,443  

Retained earnings

    120,139       122,464  

Accumulated other comprehensive loss, net of tax

    (5,359 )     (2,285 )

Total shareholders’ equity

    198,856       197,638  

Total liabilities and shareholders’ equity

  $ 415,134     $ 422,450  

 

5

 

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

   

Years Ended December 31,

 
   

2024

   

2023

 

CASH FLOWS FROM OPERATING ACTIVITIES

               

Net income

  $ 12,004     $ 8,772  

Adjustments to reconcile net income to net cash provided by operating activities:

               

Depreciation and amortization

    13,185       13,995  

Inventory write-downs

    2,423       2,346  

Share-based compensation expense

    4,270       3,787  

Deferred income tax benefit

    (1,581 )     (1,635 )

Change in fair value of acquisition-related contingent liabilities

    437       (189 )

Change in fair value of written put options

    653       489  

Other, net

    739       749  

Changes in assets and liabilities, net of acquisition of businesses:

               

Accounts receivable

    7,977       1,051  

Contract assets

    (3,434 )     4,310  

Inventories

    (1,031 )     24,672  

Prepaid expenses and other current assets

    (2,375 )     8,515  

Other assets

    (2,953 )     (2,222 )

Accounts payable and other current liabilities

    1,934       13,310  

Payment of acquisition-related contingent liabilities

    (686 )     (279 )

Long-term pension liability

    433       407  

Other long-term liabilities

    1,433       851  

Net cash provided by operating activities

    33,428       78,929  
                 

CASH FLOWS FROM INVESTING ACTIVITIES

               

Additions to property, plant and equipment

    (4,435 )     (4,963 )

Acquisition of businesses

    (4,000 )     -  

Other investments

    -       (545 )

Net cash used in investing activities

    (8,435 )     (5,508 )
                 

CASH FLOWS FROM FINANCING ACTIVITIES

               

Borrowings under revolving lines of credit

    47,000       6,000  

Payments under revolving lines of credit

    (50,000 )     (64,000 )

Payment of term loan

    (4,687 )     (3,750 )

Debt issuance costs

    -       (300 )

Payment of cash dividends

    (9,284 )     (9,188 )

Payment of acquisition-related contingent liabilities

    (897 )     (553 )

Proceeds received on exercise of stock options

    1,128       175  

Shares withheld for taxes

    (317 )     -  

Common stock reacquired and retired

    (7,417 )     -  

Net cash used in financing activities

    (24,474 )     (71,616 )
                 

Effect of currency exchange rates on cash

    (1,649 )     369  

Net (decrease) increase in cash and cash equivalents

    (1,130 )     2,174  

Cash and cash equivalents balance, beginning of year

    19,896       17,722  

Cash and cash equivalents balance, end of year

  $ 18,766     $ 19,896  

 

6

 

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES

NON-GAAP FINANCIAL MEASURES

(Unaudited)

(In thousands, except shares and per share data)

 

   

Three Months Ended December 31,

   

Years Ended December 31,

 
   

2024

   

2023

   

2024

   

2023

 

Net income

  $ 2,089     $ 3,557     $ 12,004     $ 8,772  

Interest expense

    1,461       2,060       6,358       9,718  

Income tax expense

    390       617       2,290       997  

Depreciation and amortization

    3,313       3,664       13,185       13,995  

Intangible assets impairment charge

    -       -       260       -  

EBITDA(1)

  $ 7,253     $ 9,898     $ 34,097     $ 33,482  

EBITDA margin(1)

    5.0 %     6.7 %     6.0 %     6.2 %
                                 
                                 

 

(1) EBITDA, which is a non-GAAP financial measure, is defined as net income excluding interest expense, income tax expense, depreciation and amortization expense and impairment charges. EBITDA margin is defined as EBITDA divided by net sales. The Company believes EBITDA is an important measure of operating performance because it allows management, investors and others to evaluate and compare the Company’s core operating results from period to period by removing (i) the impact of the Company’s capital structure (interest expense from outstanding debt), (ii) tax consequences and (iii) asset base (depreciation and amortization and impairment charges). The Company uses EBITDA internally to monitor operating results and to evaluate the performance of its business. In addition, the compensation committee has used EBITDA in evaluating certain components of executive compensation, including performance-based annual incentive programs. EBITDA is not a measure of financial performance under GAAP.  EBITDA should not be considered in isolation or as an alternative to net income, cash flows from operating activities or any other measure determined in accordance with GAAP. The items excluded to calculate EBITDA are significant components in understanding and assessing the Company’s results of operations. The presentation of the Company’s EBITDA may change from time to time, including as a result of changed business conditions, new accounting pronouncements or otherwise. If the presentation changes, the Company undertakes to disclose any change between periods and the reasons underlying that change. The Company’s EBITDA may not be comparable to a similarly titled measure of another company because other entities may not calculate EBITDA in the same manner.

 

7

 

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES

SUPPLEMENTAL INFORMATION - REPORTABLE SEGMENTS

(Unaudited)

(In thousands)

 

   

Branded Products

   

Healthcare Apparel

   

Contact Centers

   

Intersegment Eliminations

   

Other

   

Total

 

For the Year Ended December 31, 2024:

                                               

Net sales

  $ 353,314     $ 119,191     $ 96,949     $ (3,778 )   $ -     $ 565,676  

Cost of goods sold

    228,591       73,445       44,742       (1,680 )     -       345,098  

Gross margin

    124,723       45,746       52,207       (2,098 )     -       220,578  

Selling and administrative expenses

    94,384       41,149       42,999       (2,098 )     23,492       199,926  

Add: Depreciation and amortization

    5,948       3,892       2,968       -       377       13,185  

Intangible assets impairment charge

    -       260       -       -       -       260  

Segment EBITDA(1)

  $ 36,287     $ 8,749     $ 12,176     $ -     $ (23,115 )   $ 34,097  
                                                 
   

Branded Products

   

Healthcare Apparel

   

Contact Centers

   

Intersegment Eliminations

   

Other

   

Total

 

For the Year Ended December 31, 2023:

                                               

Net sales

  $ 342,680     $ 113,878     $ 91,500     $ (4,756 )   $ -     $ 543,302  

Cost of goods sold

    228,053       71,597       42,352       (2,247 )     -       339,755  

Gross margin

    114,627       42,281       49,148       (2,509 )     -       203,547  

Selling and administrative expenses

    88,225       38,209       39,682       (2,509 )     20,453       184,060  

Add: Depreciation and amortization

    6,744       3,925       2,942       -       384       13,995  

Segment EBITDA(1)

  $ 33,146     $ 7,997     $ 12,408     $ -     $ (20,069 )   $ 33,482  

 

8

 

   

Branded Products

   

Healthcare Apparel

   

Contact Centers

   

Intersegment Eliminations

   

Other

   

Total

 

For the Three Months Ended December 31, 2024:

                                               

Net sales

  $ 92,403     $ 30,337     $ 23,527     $ (859 )   $ -     $ 145,408  

Cost of goods sold

    61,057       20,110       10,667       (386 )     -       91,448  

Gross margin

    31,346       10,227       12,860       (473 )     -       53,960  

Selling and administrative expenses

    23,898       10,218       10,563       (473 )     5,814       50,020  

Add: Depreciation and amortization

    1,435       1,055       722       -       101       3,313  

Segment EBITDA(1)

  $ 8,883     $ 1,064     $ 3,019     $ -     $ (5,713 )   $ 7,253  
                                                 
   

Branded Products

   

Healthcare Apparel

   

Contact Centers

   

Intersegment Eliminations

   

Other

   

Total

 

For the Three Months Ended December 31, 2023:

                                               

Net sales

  $ 97,725     $ 28,003     $ 22,565     $ (1,052 )   $ -     $ 147,241  

Cost of goods sold

    63,561       17,725       10,807       (497 )     -       91,596  

Gross margin

    34,164       10,278       11,758       (555 )     -       55,645  

Selling and administrative expenses

    24,392       9,748       10,180       (555 )     5,646       49,411  

Add: Depreciation and amortization

    1,918       911       732       -       103       3,664  

Segment EBITDA(1)

  $ 11,690     $ 1,441     $ 2,310     $ -     $ (5,543 )   $ 9,898  

 

(1) Segment EBITDA is our primary measure of segment profitability under U.S. GAAP ASC 280 “Segment Reporting”. Amounts included in income before income tax expense and excluded from Segment Adjusted EBITDA include: interest expense, depreciation and amortization expense, impairment charges and any other items not tied to the operational performance of the segment. Total Segment EBITDA is a non-GAAP financial measure. Please see reconciliation of Adjusted EBITDA included in the Non-GAAP Financial Measures table above.

 

9